Citation tools
"T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial." The Journal of Immunology
(2022):
ji2101076.
Web. 08 Aug. 2022.